These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 602311)

  • 1. [Occurrence and behavior of fibrin fibrinogen degradation products in concentrates of factor VIII, cryoprecipitate and dextran precipitate during long-term preservation].
    Kätzel R; Wegner H
    Z Gesamte Inn Med; 1977 Nov; 32(22):603-11. PubMed ID: 602311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of in vivo analysis of injected fibrinogen degradation products and factor VIII in patients with hemophilia A].
    Kätzel R; Kubel M; Scheel H; Wegner H
    Z Gesamte Inn Med; 1978 Aug; 33(15):525-9. PubMed ID: 695793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can storage of thawed cryoprecipitate be extended to more than six hours?
    Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
    Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in hemophilia.
    Tann G
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):218-28. PubMed ID: 524146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
    Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
    Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Self-sufficiency with factor VIII in Norway. Use of freeze-dried cryoprecipitates instead of purified factor VIII concentrates].
    Solheim BG; Evensen SA; Stavem P; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):16-8. PubMed ID: 3082031
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemoglobin production in human bone marrow cultures is inhibited by lyophilized coagulation factor concentrates.
    Andes WA; Makris CM; Beltran G; Stuckey WJ
    Am J Med Sci; 1986 Apr; 291(4):211-4. PubMed ID: 3085496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precipitation of fibrin monomers and fibrin degradation products by ristocetin.
    Watanabe K; Tullis JL
    Am J Med Sci; 1978; 275(3):337-44. PubMed ID: 80134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin in liquid and frozen stored blood components.
    Snyder EL; Ferri PM; Mosher DF
    Transfusion; 1984; 24(1):53-6. PubMed ID: 6420955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

  • 14. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 15. The preparation of fibrinogen concentrate for use as fibrin glue by four different methods.
    DePalma L; Criss VR; Luban NL
    Transfusion; 1993 Sep; 33(9):717-20. PubMed ID: 8212116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Research Analysis.
    Sparrow RL; Simpson RJ; Greening DW
    Methods Mol Biol; 2023; 2628():41-49. PubMed ID: 36781778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of plasma fibrinogen during storage of platelet concentrates at 22 degrees C.
    Murphy S; Martinez J; Holburn R
    Transfusion; 1983; 23(6):480-3. PubMed ID: 6649024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protocol for the preparation of cryoprecipitate and cryodepleted plasma.
    Sparrow RL; Greening DW; Simpson RJ
    Methods Mol Biol; 2011; 728():259-65. PubMed ID: 21468954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen and its derivatives: cofactors in the intrinsic generation of thrombin.
    Triantaphyllopoulos DC; Ryan LT
    Thromb Haemost; 1976 Apr; 35(2):305-13. PubMed ID: 989630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of freeze-drying, freezing and frozen storage of blood plasma on fibrin network characteristics.
    Pieters M; Jerling JC; Weisel JW
    Thromb Res; 2002 Sep; 107(5):263-9. PubMed ID: 12479888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.